How to Run Nutra Offers on Google Ads Without Getting Banned

Most nutra affiliates think they have a healthcare policy problem.

The data says otherwise. I'm Mike, and I review payment and account setups here at YeezyPay. I spend a lot of my week looking at suspended accounts, and the nutra vertical shows up more than any other. So when Google published its 2025 Ads Safety Report in April 2026, I went straight to the enforcement breakdown to see which policy was actually doing the damage. The answer surprised me, and it should change how you build your campaigns.

Google removed 87.8 million ads under its Healthcare and Medicines policy in 2025. That sounds like a lot until you see the number sitting at the top of the same table: 1.29 billion ads removed for Abusing the Ad Network. That's the cloaking and circumvention bucket. It's roughly fifteen times bigger.

Read that again, because it reframes everything. Nutra advertisers don't mostly die because their product is a supplement. They die because of how they hide the funnel and how they word the claim.

What Counts as Nutra, and Why Google Treats It Differently

"Nutra" is affiliate shorthand for nutraceuticals. In practice it covers five sub-verticals: weight loss, male enhancement and sexual health, skincare and anti-aging, general wellness supplements like joint or brain formulas, and the newer telehealth-adjacent offers built around prescription weight-loss drugs.

Google doesn't have a policy called "nutra." That's the first thing people get wrong. What you're actually up against is five or six separate policies that all happen to converge on the same offers. Each one has a different enforcement style, and knowing which is which is the difference between a warning email and a dead account.

The product is rarely the problem. The claim and the funnel usually are.

The 2025 Numbers, and What Changed

Google's 2025 Ads Safety Report landed on April 16, 2026. Two numbers moved in opposite directions, and the story is in the gap between them.

Metric	2024	2025
Ads blocked or removed	5.1B	8.3B+
Advertiser accounts suspended	39.2M	24.9M+
Ads restricted	9.1B	4.8B+
Web pages blocked or restricted	1.3B	480M+
Policy updates made	—	35

More ads killed, far fewer accounts killed. Google's explanation is precision: enforcement moved from the account level down to the ad level, and it credits Gemini-based review with cutting incorrect advertiser suspensions by 80%. Over 99% of violating ads were stopped before they ever served.

Here's my read on that, and it's an opinion rather than a fact. The old survival strategy in this vertical was "buy more accounts than Google can burn." That strategy is aging badly. When enforcement gets surgical, volume stops protecting you, and the advertiser who wrote a compliant ad in the first place gets to keep spending while everyone else refreshes their inbox. Compliance stopped being the slow lane.

The policy-level breakdown for ads removed in 2025 tells you where to aim your attention:

Policy	Ads removed (2025)
Abusing the Ad Network (cloaking, circumvention)	1.29B+
Personalization Violations	755M+
Legal Requirements	646.7M+
Misrepresentation	421.5M+
Financial Services	327.8M+
Healthcare and Medicines	87.8M+

Warning vs No Warning: The Distinction That Saves Accounts

Not every nutra violation carries the same penalty. This is the single most useful thing to internalize, and almost nobody in the affiliate forums separates the two properly.

Google's Unapproved substances policy is graduated. Google states plainly that "a warning will be issued at least 7 days prior to any suspension." Sell something on the prohibited list and you generally get a chance to pull it down. That's survivable.

The Misrepresentation policy is not graduated. Google's own wording: "your Google Ads accounts will be suspended upon detection and without prior warning." Unreliable claims and clickbait ads both sit inside it. So the "1 weird trick" headline is a bigger legal exposure than the ingredient in the bottle.

Then there's Abusing the ad network. Google classes circumventing systems as an egregious violation: suspension on detection, no warning, and reinstatement only "in compelling circumstances." Cloaking, evasive ad content, bridge and gateway pages all live here. This is the 1.29 billion bucket, and it's the one you should treat as unappealable. I won't pretend there's a clever version of it. There isn't a version I'd recommend to anyone whose money runs through our rails.

Banned, Restricted, Allowed: A 2026 Triage

Google doesn't publish one consolidated table, so this is my synthesis of several policies rather than a single official page. Check each line against the policy it links to before you build on it.

Outright banned. Ephedra products. hCG for weight loss. Supplements spiked with active pharmaceutical ingredients. Anabolic steroids and prohormones, including the named ones on Google's unapproved pharmaceuticals and supplements list. Anything claiming to cure or treat a disease without government approval. Anything implying equivalence to a prescription drug. Ingestible CBD, entirely. DHEA anywhere outside US-targeted campaigns.

That list of named products is worth reading once. Google names specific brands: Lishou, Magic Slim Tea, Dream Body Slimming Capsule on the weight-loss side; Stamina-Rx, Libiplus, Zenerect on the ED side; Halodrol, Superdrol, M-Drol among the anabolics. If your offer is a rebrand of one of these, the ingredient list will get matched sooner or later.

Restricted, meaning certification or location gated. Online pharmacies, telemedicine and addiction treatment require LegitScript certification. Prescription drug terms, including GLP-1s, are promotionally permitted only in the US, Canada and New Zealand, and need certification plus formal authorization from the advertiser's healthcare organization. Topical CBD needs LegitScript plus targeting limited to California, Colorado and Puerto Rico. Sexual health products face 18+ targeting rules and are largely prohibited outside the US and Canada.

Generally allowed with no certification. Ordinary physical, non-prescription supplements. Vitamins, minerals, protein, collagen, general wellness, non-medicated skincare. The conditions are that your claims stay structure-and-function rather than disease, and your targeting avoids sensitive health segmentation. One caveat: subscription and trial-rebill health offers have been under increased scrutiny since late 2025, and that's the classic nutra funnel, so treat it as a live risk area rather than a settled one.

What LegitScript Actually Unlocks

People ask me about LegitScript constantly, usually hoping it's a skeleton key for supplements. It isn't.

As of the April 8, 2026 expansion, Google recognizes LegitScript certification across the US, UK, Canada, France, Australia, Indonesia, the Philippines and South Africa, with India newly added for pharmacies and New Zealand for telemedicine. Cost runs to a $975 non-refundable application fee per website plus roughly $2,150 per website annually, and LegitScript publishes no timeline because "each application review is unique." Verify current pricing on their site before you budget for it.

Two things matter here. Certification makes you eligible to apply to Google; Google's approval is a separate step. And a certified pharmacy can still lose an individual ad over its copy. More importantly for most readers: certification covers pharmacies, telemedicine, addiction treatment and topical CBD. It is not a path to advertising generic nutra supplements. If your offer is restricted, the realistic fix is to make it non-restricted, not to certify around it.

Writing Claims That Survive Review

The standard you're being judged against isn't Google's. It's the FTC's.

The FTC's Health Products Compliance Guidance, published December 2022 to replace the old 1998 supplement guides, requires "competent and reliable scientific evidence" behind health claims. For a health-benefit claim, that generally means randomized, controlled human clinical testing. Structure and function claims survive that bar. Disease claims don't. Google's reviewers are effectively enforcing a downstream version of the same rule.

Testimonials deserve their own paragraph because affiliates keep getting this backwards. The FTC treats a testimonial as the advertiser's own claim. If the result isn't substantiated for typical users, you can't run it even when it's literally true for that one customer. In 2025 the FTC put nearly 700 marketers on notice of civil penalty exposure covering endorsement misrepresentation, fake reviews and undisclosed material connections. That's not a theoretical risk.

Before-and-after imagery gets scrutinized on net impression, meaning the ad as a whole rather than the disclaimer at the bottom. Atypical transformations need typical-results disclosure, and manipulated imagery trips Google's Misrepresentation policy separately. The enforcement precedent is recent: the FTC's action against NextMed over GLP-1 telehealth marketing was announced July 14, 2025 and finalized December 3, 2025, covering undisclosed costs, unsubstantiated weight-loss claims and distorted reviews.

There's also a targeting trap that catches careful advertisers. Under Google's health in personalized advertising rules, health is a sensitive interest category. That means no Customer Match, no advertiser-curated audiences, no data segments, no lookalikes, no audience expansion on weight loss, ED or diabetes offers. Predefined Google audiences, in-market, affinity, demographics and location still work. Plenty of people build a perfectly compliant funnel and then break the policy in the audience tab.

Take the Payment Layer Off the Table

Compliance work is wasted if your billing keeps flagging. If you're advertising from a country where Google won't accept your local cards, or your payments keep tripping risk checks, YeezyPay gives you agency accounts with stable, accepted payment rails and deposits that don't look suspicious to Google's billing systems. It won't make a non-compliant funnel compliant. It does remove the one failure mode that has nothing to do with your offer.

Billing Suspensions and the Silent Killer Nobody Diagnoses

Google's billing policy names four official suspension triggers: unpaid balances or concerns about ability to pay, suspicious payment activity, chargebacks against legitimate Google charges, and promotional code abuse. Google distinguishes a pause, which you fix by confirming a payment method or settling a balance, from a suspension, which needs an appeal and a payment verification request with a 30-day window.

In practice the patterns we see most often are narrower than the policy text. Prepaid cards no longer work for automatic payments. Cards not in the account holder's name get flagged. Billing country not matching target country draws attention. Frequent payment method changes look like exactly what Google is watching for.

Then there's the one that sends people down a rabbit hole for weeks: Limited Ad Serving. Google throttles impressions for advertisers it hasn't established trust in yet, based on account maturity, compliance history, user reports and verification status. You get an in-account notification, not an ad disapproval. So the symptom is "my new nutra account spends nothing and I can't see why," and people go rewrite perfectly fine ad copy for a week. The exits are full policy compliance, advertiser verification, positive engagement history, or the Limited Ad Serving Appeals Form. Google's August 2026 update expands this to all Google Ads products with rollout completing in 2028, so it's going to get more common, not less.

Where Agency Accounts Genuinely Help, and Where They Don't

First, a terminology fix, because the industry blurs these constantly. An MCC or Manager Account is a free Google management layer you set up yourself. An "agency account" in media buying means a rented account inside somebody else's aged, high-spend, trusted manager structure. Different things.

The honest case for the rented version: account trust affects approval speed, spend limits and how quickly a marginal ad gets a human look. Established manager structures come with priority moderation and payment rails that work for advertisers whose local methods Google won't take. For anyone in a restricted country running nutra, that second part is often the whole reason.

Here's the counterweight I give people who ask us for agency accounts, and it costs us business sometimes. A severe violation inside a manager structure can make Google treat the manager as the common denominator and take action across the tree. Concentration risk is real. And Google's 2025 pivot toward ad-level enforcement, plus that 80% drop in incorrect suspensions, quietly erodes the old premise that a trusted account absorbs anything. An agency account improves your payment stability and your trust signals. It does not immunize a cloaked funnel or an unsubstantiated claim.

An example from our own desk. Earlier this year an affiliate came to us after losing three accounts in six weeks on a weight-loss offer. He assumed it was the vertical and wanted a fresh account to keep going. We looked at the funnel first. The offer itself was a plain non-prescription supplement, entirely allowed. What killed him was a pre-lander built as a fake news article with a before-and-after that no disclaimer could rescue, plus a Customer Match list he'd uploaded for retargeting. Two separate no-warning policies, neither of them healthcare. He rewrote the lander as an actual product page, dropped the audience list, and moved billing onto a stable card through us. That account is still running. A fourth throwaway account would have burned in the same three weeks.

A Practical Checklist Before You Launch

• Check your ingredient list against Google's unapproved pharmaceuticals and unapproved substances pages. If anything matches, change the product, not the wording.
• Strip every disease claim. Keep structure and function language only.
• Kill clickbait headlines. "Unreliable claims" and "clickbait" carry no warning period.
• Make the landing page a real page. If deleting the buy button leaves nothing useful, it reads as a bridge page.
• Serve the same page to reviewers and to users. No exceptions, no geo tricks.
• Remove Customer Match, lookalikes and audience expansion from health campaigns.
• Scrub URL parameters and form fields so health data doesn't leak into your tracking.
• Keep restricted drug terms out of keywords unless you're certified and in the US, Canada or New Zealand.
• Use one stable, correctly named payment method in a country that matches your setup.
• If impressions are near zero with no disapprovals, check for Limited Ad Serving before you touch the creative.

The Short Version

Nutra isn't banned on Google Ads. Large parts of it are ordinary restricted-category advertising that plenty of people run profitably.

What gets punished hardest is hiding and overpromising. The 2025 enforcement data makes that concrete: 1.29 billion ads removed for circumvention against 87.8 million for healthcare. If you build a compliant claim on a real page and take the payment variable out of the equation, you're competing on media buying rather than on how long your latest account survives. That's a much better business.

Policies in this space move fast. Everything here was verified against Google's published policies and the 2025 Ads Safety Report as of September 2026, and I'd recheck the linked pages quarterly.